Navigation Links
Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis
Date:5/18/2009

th in Orlando, Florida.

About PX-866

PX-866 is an inhibitor of the PI-3-kinase/PTEN/AKT pathway, an important survival signaling pathway that is activated in many types of human cancer. Aberrant activation and regulation of PI-3 kinase is implicated in a large proportion of human cancers including breast, glioma, colon, ovarian, prostate and melanoma, where it leads to increased proliferation and inhibition of apoptosis (programmed cell death). PX-866 has been shown to induce prolonged inhibition of tumor PI-3 kinase signaling following both oral and intravenous administration. The compound has been shown to have anti-tumor activity both as a single agent and in combination with other agents in a number of human tumor models. Oncothyreon initiated a Phase 1 trial of PX-866 in patients with advanced metastatic cancer in June 2008.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.

Forward-Looking Statements

In order to provide Oncothyreon's investors with an understanding of its current intentions and future prospects, this release contains statements that are forward-looking, including statements related to future preclinical and clinical development plans for PX PX-866. These forward-looking statements represent Oncothyreon's intentions, plans, expectations and beliefs and are based on its management's experience and assessment of historical and future trends and the application of key assumptions relating to future events and circumstances.

Forward-looking statements involve
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Data for Oncothyreons PX-12 and PX-866 presented at AACR Annual Meeting
2. Oncothyreon files investigational new drug application for PX-866 oncology compound
3. Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
4. Phase III Trial Finds Pharmaxis Bronchitol Effective
5. New nanoparticle vaccine is more effective but less expensive
6. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
7. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
8. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
9. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
10. Free White Paper Available for Clinical Laboratory Managers: Effectively Isolating Anaerobic Bacteria
11. DNA sensors found to be an effective artificial nose
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Ill. , May 23, 2013 Z ... providing value-added ingredients to a variety of industries, announced ... in a panel discussion at this year,s National Restaurant ... 20-21, 2013, on behalf of the Research Chefs Association.  ... for Restaurants: The Good, the Bad and the Ugly," ...
(Date:5/23/2013)... , May 23, 2013 Pressure BioSciences, Inc. ... the Company will host a teleconference to discuss its ... business update. The teleconference information is provided below: ... Eastern Daylight Time (EDT) Dial-in: (800) 875-3456 ... 607-2001 (Int,l) Passcode: VS22823 For those unable ...
(Date:5/23/2013)... , May 23, 2013 Pusan ... Inc., a private biotherapeutics and contract research company ... products for cancer, announced today a publication reporting ... treated with the oncolytic and immunotherapeutic vaccinia JX-594 ... research was published in the May 15 th ...
(Date:5/23/2013)... Bed bugs already cost Alton Housing Authority thousands. ... a report from kmov.com suggested that the said office might ... Meanwhile, to be of help, My Cleaning Products gave tips ... bug exterminator service. , The report, which was posted ... spent $35,000 for bed bug elimination, My Cleaning ...
Breaking Biology Technology:Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3Bed Bug Exterminator Service Could Cost AHA $250K, My Cleaning Products Gives Tips How to Save Apartments from Costly Bed Bug Treatment 2
... third-party plug-in for popular embedded tool suite. , ... ... Quadros Systems, Inc., a leading supplier of configurable and scalable ... module for the RTXC Quadros RTOS is now available for ...
... on Tuesday, July 15 at 4:30 p.m. Eastern -, ... VRML ), a molecular diagnostics company, will host a ... Ueland,M.D., Principal Investigator on the submission and Associate Professor ... the keynote,speaker of the roundtable., Vermillion,s ovarian tumor ...
... 11 Signalife,Inc. (Amex: SGN ) announced ... its previously-announced merger or similar business combination with,Heart ... has been,appointed to proceed with due diligence and ... presently contemplated, a new parent,company will be established ...
Cached Biology Technology:RTXC Kernel Awareness Module from Quadros Systems Now Available for Keil Vision Debugger 2RTXC Kernel Awareness Module from Quadros Systems Now Available for Keil Vision Debugger 3RTXC Kernel Awareness Module from Quadros Systems Now Available for Keil Vision Debugger 4Vermillion to Host Live Roundtable Discussion With Principal Investigator of OVA1(TM) Submission 2Vermillion to Host Live Roundtable Discussion With Principal Investigator of OVA1(TM) Submission 3Signalife Board Approves Merger 2Signalife Board Approves Merger 3
(Date:5/22/2013)... have developed a novel technique that can detect molecular ... that is one of the most important, though time-consuming, ... a paper in Nature , post-doctoral researcher David ... Schnell of the Center for Free-Electron Laser Science (CFEL) ... finely-tuned microwave fields to identify molecular variants apart, and ...
(Date:5/22/2013)... and human health effects from disposal of millions ... scientists to recommend stronger government policies to encourage ... materials. That,s the conclusion of a new paper ... Technology . , Oladele A. Ogunseitan and colleagues ... for powering everything from smart phones to components ...
(Date:5/22/2013)... May 22, 2013 Early screening for prostate cancer ... testing is for women, thanks to UC Irvine research ... Chemical Society . , After more than a decade ... to clearly identify clinically usable markers for prostate cancer ... far sooner, with greater accuracy and at dramatically lower ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3
... University of Minnesota,s Water Resources Center has authored a ... lakes, rivers and groundwater for the 21st century and ... Minnesota House of Representative,s Environment, Energy and Natural Resources ... Jan. 5 in Room 5 of the State Office ...
... Unisys Corporation (NYSE: UIS ... next year, Unisys predicts, six disruptive technology trends that are ... in the enterprise as organizations seek practical ways to make ... secure and cost-efficient. "Practicality will be the theme ...
... January 4, 2011 Researchers from The Scripps ... produced a long-lasting anti-cocaine immunity in mice by giving them ... virus with a particle that mimics cocaine. In their ... of Molecular Therapy , the researchers say this novel ...
Cached Biology News:U of Minnesota center releases nation's first long-term framework for statewide water sustainability 2From Disruptive to Productive: Unisys Predicts 2011 to be Year of Practical Application of Cutting-Edge Technologies 2From Disruptive to Productive: Unisys Predicts 2011 to be Year of Practical Application of Cutting-Edge Technologies 3From Disruptive to Productive: Unisys Predicts 2011 to be Year of Practical Application of Cutting-Edge Technologies 4From Disruptive to Productive: Unisys Predicts 2011 to be Year of Practical Application of Cutting-Edge Technologies 5Team creates novel vaccine that produces strong immunity against cocaine high 2Team creates novel vaccine that produces strong immunity against cocaine high 3Team creates novel vaccine that produces strong immunity against cocaine high 4
...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
Goat anti-VAV2 Class: Antibody Product Group: Miscellaneous Antibody...
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
Biology Products: